NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

NKGen Biotech, Inc. SANTA ANA, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, M.D., Chairman and Chief Executive Officer of NKGen,…

Read More
Tims China Announces First Quarter 2025 Financial Results

Tims China Announces First Quarter 2025 Financial Results

Mr. Dong (Albert) Li, CFO of Tims China, commented, “We continued to demonstrate our capabilities to further improving our financial performance by refining store unit economics and driving efficiencies at both store and corporate levels. We further improved our company owned and operated store contribution margin and adjusted corporate EBITDA margin by 5.9 percentage points…

Read More
Autohome Shines at 2025 Hong Kong Auto Expo, Empowering Automakers to Go Global with One-Stop Solutions

Autohome Shines at 2025 Hong Kong Auto Expo, Empowering Automakers to Go Global with One-Stop Solutions

HONG KONG, June 12, 2025 /PRNewswire/ — The 2025 International Automotive & Supply Chain Expo (Hong Kong) (“Hong Kong Auto Expo” or the “Expo”) kicked off today at AsiaWorld-Expo in Hong Kong. As the chief strategic automotive media partner of the event, Autohome Inc. (NYSE: ATHM; HKEX: 2518) (“Autohome” or the “Company”) provided comprehensive coverage…

Read More